nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycine—SLC6A5—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—Gilles de la Tourette syndrome	0.0307	0.0842	CbGpPWpGaD
Glycine—SLC6A9—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—Gilles de la Tourette syndrome	0.0307	0.0842	CbGpPWpGaD
Glycine—GPR18—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0224	0.0615	CbGpPWpGaD
Glycine—SLC6A9—Amine compound SLC transporters—SLC6A3—Gilles de la Tourette syndrome	0.0213	0.0584	CbGpPWpGaD
Glycine—SLC6A5—Amine compound SLC transporters—SLC6A3—Gilles de la Tourette syndrome	0.0213	0.0584	CbGpPWpGaD
Glycine—SLC6A5—nervous system—Gilles de la Tourette syndrome	0.0187	0.0294	CbGeAlD
Glycine—SLC6A5—central nervous system—Gilles de la Tourette syndrome	0.018	0.0283	CbGeAlD
Glycine—SLC6A9—midbrain—Gilles de la Tourette syndrome	0.0172	0.0271	CbGeAlD
Glycine—GLYATL2—nervous system—Gilles de la Tourette syndrome	0.0159	0.025	CbGeAlD
Glycine—GLYATL2—central nervous system—Gilles de la Tourette syndrome	0.0153	0.0241	CbGeAlD
Glycine—SLC32A1—nervous system—Gilles de la Tourette syndrome	0.0147	0.0231	CbGeAlD
Glycine—SLC6A5—brain—Gilles de la Tourette syndrome	0.0143	0.0225	CbGeAlD
Glycine—SLC6A9—nervous system—Gilles de la Tourette syndrome	0.0142	0.0223	CbGeAlD
Glycine—GLRA3—nervous system—Gilles de la Tourette syndrome	0.0142	0.0223	CbGeAlD
Glycine—SLC32A1—central nervous system—Gilles de la Tourette syndrome	0.0141	0.0222	CbGeAlD
Glycine—SLC6A9—central nervous system—Gilles de la Tourette syndrome	0.0136	0.0215	CbGeAlD
Glycine—GLRA3—central nervous system—Gilles de la Tourette syndrome	0.0136	0.0215	CbGeAlD
Glycine—GATM—Amino acid and derivative metabolism—HDC—Gilles de la Tourette syndrome	0.0126	0.0345	CbGpPWpGaD
Glycine—GLYATL2—brain—Gilles de la Tourette syndrome	0.0121	0.0191	CbGeAlD
Glycine—GLRA1—nervous system—Gilles de la Tourette syndrome	0.012	0.019	CbGeAlD
Glycine—GLDC—midbrain—Gilles de la Tourette syndrome	0.0116	0.0183	CbGeAlD
Glycine—GLRA1—central nervous system—Gilles de la Tourette syndrome	0.0116	0.0182	CbGeAlD
Glycine—GCSH—nervous system—Gilles de la Tourette syndrome	0.0115	0.0182	CbGeAlD
Glycine—SLC32A1—brain—Gilles de la Tourette syndrome	0.0112	0.0176	CbGeAlD
Glycine—GCSH—central nervous system—Gilles de la Tourette syndrome	0.0111	0.0175	CbGeAlD
Glycine—PIPOX—midbrain—Gilles de la Tourette syndrome	0.0109	0.0171	CbGeAlD
Glycine—GLRA3—brain—Gilles de la Tourette syndrome	0.0108	0.017	CbGeAlD
Glycine—SLC6A9—brain—Gilles de la Tourette syndrome	0.0108	0.017	CbGeAlD
Glycine—AGXT—Amino acid and derivative metabolism—HDC—Gilles de la Tourette syndrome	0.0107	0.0293	CbGpPWpGaD
Glycine—GCAT—midbrain—Gilles de la Tourette syndrome	0.0105	0.0166	CbGeAlD
Glycine—GLRA2—nervous system—Gilles de la Tourette syndrome	0.00981	0.0155	CbGeAlD
Glycine—GLDC—nervous system—Gilles de la Tourette syndrome	0.00956	0.0151	CbGeAlD
Glycine—GLRA2—central nervous system—Gilles de la Tourette syndrome	0.00945	0.0149	CbGeAlD
Glycine—ALAS1—midbrain—Gilles de la Tourette syndrome	0.00923	0.0145	CbGeAlD
Glycine—GLDC—central nervous system—Gilles de la Tourette syndrome	0.00921	0.0145	CbGeAlD
Glycine—AGXT2—Amino acid and derivative metabolism—HDC—Gilles de la Tourette syndrome	0.00909	0.0249	CbGpPWpGaD
Glycine—PIPOX—nervous system—Gilles de la Tourette syndrome	0.00893	0.0141	CbGeAlD
Glycine—GCSH—brain—Gilles de la Tourette syndrome	0.00882	0.0139	CbGeAlD
Glycine—GRIN2C—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.0088	0.0241	CbGpPWpGaD
Glycine—GCAT—nervous system—Gilles de la Tourette syndrome	0.00866	0.0136	CbGeAlD
Glycine—PIPOX—central nervous system—Gilles de la Tourette syndrome	0.0086	0.0135	CbGeAlD
Glycine—GPR18—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.0085	0.0233	CbGpPWpGaD
Glycine—GARS—midbrain—Gilles de la Tourette syndrome	0.00841	0.0132	CbGeAlD
Glycine—GCAT—central nervous system—Gilles de la Tourette syndrome	0.00834	0.0131	CbGeAlD
Glycine—SLC6A9—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.00834	0.0229	CbGpPWpGaD
Glycine—SLC6A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.00834	0.0229	CbGpPWpGaD
Glycine—GPR18—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00825	0.0226	CbGpPWpGaD
Glycine—GRIN2C—Hypothetical Network for Drug Addiction—DRD2—Gilles de la Tourette syndrome	0.0082	0.0225	CbGpPWpGaD
Glycine—GATM—midbrain—Gilles de la Tourette syndrome	0.00798	0.0126	CbGeAlD
Glycine—GNMT—brain—Gilles de la Tourette syndrome	0.00771	0.0121	CbGeAlD
Glycine—ALAS1—nervous system—Gilles de la Tourette syndrome	0.00759	0.012	CbGeAlD
Glycine—GLRA2—brain—Gilles de la Tourette syndrome	0.0075	0.0118	CbGeAlD
Glycine—SHMT1—Amino acid and derivative metabolism—HDC—Gilles de la Tourette syndrome	0.00741	0.0203	CbGpPWpGaD
Glycine—SHMT2—midbrain—Gilles de la Tourette syndrome	0.00732	0.0115	CbGeAlD
Glycine—GLDC—brain—Gilles de la Tourette syndrome	0.00731	0.0115	CbGeAlD
Glycine—ALAS1—central nervous system—Gilles de la Tourette syndrome	0.00731	0.0115	CbGeAlD
Glycine—GARS—nervous system—Gilles de la Tourette syndrome	0.00691	0.0109	CbGeAlD
Glycine—GLRB—midbrain—Gilles de la Tourette syndrome	0.00686	0.0108	CbGeAlD
Glycine—PIPOX—brain—Gilles de la Tourette syndrome	0.00682	0.0107	CbGeAlD
Glycine—GRIN2C—nervous system—Gilles de la Tourette syndrome	0.0068	0.0107	CbGeAlD
Glycine—GRIN2A—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.00672	0.0184	CbGpPWpGaD
Glycine—GARS—central nervous system—Gilles de la Tourette syndrome	0.00666	0.0105	CbGeAlD
Glycine—GCAT—brain—Gilles de la Tourette syndrome	0.00662	0.0104	CbGeAlD
Glycine—GATM—nervous system—Gilles de la Tourette syndrome	0.00656	0.0103	CbGeAlD
Glycine—GRIN2C—central nervous system—Gilles de la Tourette syndrome	0.00655	0.0103	CbGeAlD
Glycine—GATM—central nervous system—Gilles de la Tourette syndrome	0.00632	0.00995	CbGeAlD
Glycine—GRIN2A—Hypothetical Network for Drug Addiction—DRD2—Gilles de la Tourette syndrome	0.00626	0.0172	CbGpPWpGaD
Glycine—SHMT2—nervous system—Gilles de la Tourette syndrome	0.00602	0.00947	CbGeAlD
Glycine—SLC6A9—NRF2 pathway—SLC6A3—Gilles de la Tourette syndrome	0.00601	0.0165	CbGpPWpGaD
Glycine—SLC6A5—NRF2 pathway—SLC6A3—Gilles de la Tourette syndrome	0.00601	0.0165	CbGpPWpGaD
Glycine—ALAS1—brain—Gilles de la Tourette syndrome	0.0058	0.00914	CbGeAlD
Glycine—SHMT2—central nervous system—Gilles de la Tourette syndrome	0.00579	0.00912	CbGeAlD
Glycine—GRIN2A—midbrain—Gilles de la Tourette syndrome	0.00572	0.009	CbGeAlD
Glycine—GLRB—nervous system—Gilles de la Tourette syndrome	0.00564	0.00887	CbGeAlD
Glycine—SHMT1—nervous system—Gilles de la Tourette syndrome	0.00548	0.00862	CbGeAlD
Glycine—GLRB—central nervous system—Gilles de la Tourette syndrome	0.00543	0.00854	CbGeAlD
Glycine—GPR18—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00538	0.0148	CbGpPWpGaD
Glycine—GARS—brain—Gilles de la Tourette syndrome	0.00529	0.00832	CbGeAlD
Glycine—SHMT1—central nervous system—Gilles de la Tourette syndrome	0.00527	0.0083	CbGeAlD
Glycine—GRIN2C—brain—Gilles de la Tourette syndrome	0.0052	0.00819	CbGeAlD
Glycine—GATM—brain—Gilles de la Tourette syndrome	0.00502	0.0079	CbGeAlD
Glycine—GSS—midbrain—Gilles de la Tourette syndrome	0.005	0.00787	CbGeAlD
Glycine—GRIN2A—nervous system—Gilles de la Tourette syndrome	0.0047	0.0074	CbGeAlD
Glycine—SLC36A1—nervous system—Gilles de la Tourette syndrome	0.00467	0.00735	CbGeAlD
Glycine—SHMT2—brain—Gilles de la Tourette syndrome	0.0046	0.00724	CbGeAlD
Glycine—GRIN2A—central nervous system—Gilles de la Tourette syndrome	0.00453	0.00712	CbGeAlD
Glycine—SLC36A1—central nervous system—Gilles de la Tourette syndrome	0.0045	0.00708	CbGeAlD
Glycine—GLRB—brain—Gilles de la Tourette syndrome	0.00431	0.00678	CbGeAlD
Glycine—SHMT1—brain—Gilles de la Tourette syndrome	0.00419	0.00659	CbGeAlD
Glycine—GSS—nervous system—Gilles de la Tourette syndrome	0.00411	0.00647	CbGeAlD
Glycine—GPR18—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00398	0.0109	CbGpPWpGaD
Glycine—SLC32A1—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00397	0.0109	CbGpPWpGaD
Glycine—GSS—central nervous system—Gilles de la Tourette syndrome	0.00396	0.00623	CbGeAlD
Glycine—GPR18—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00386	0.0106	CbGpPWpGaD
Glycine—SLC6A9—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00379	0.0104	CbGpPWpGaD
Glycine—SLC6A5—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00379	0.0104	CbGpPWpGaD
Glycine—GPR18—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00369	0.0101	CbGpPWpGaD
Glycine—GPR18—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.0036	0.00986	CbGpPWpGaD
Glycine—GRIN2A—brain—Gilles de la Tourette syndrome	0.00359	0.00566	CbGeAlD
Glycine—GPR18—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00358	0.00982	CbGpPWpGaD
Glycine—SLC36A1—brain—Gilles de la Tourette syndrome	0.00357	0.00562	CbGeAlD
Glycine—GPR18—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00334	0.00915	CbGpPWpGaD
Glycine—SLC32A1—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00322	0.00883	CbGpPWpGaD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00316	0.00867	CbGpPWpGaD
Glycine—GSS—brain—Gilles de la Tourette syndrome	0.00314	0.00495	CbGeAlD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00307	0.00842	CbGpPWpGaD
Glycine—ALAS2—Metabolism—HDC—Gilles de la Tourette syndrome	0.00305	0.00835	CbGpPWpGaD
Glycine—SLC32A1—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00304	0.00834	CbGpPWpGaD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00286	0.00784	CbGpPWpGaD
Glycine—GPR18—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00241	0.0066	CbGpPWpGaD
Glycine—GPR18—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00234	0.00641	CbGpPWpGaD
Glycine—GPR18—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00234	0.00641	CbGpPWpGaD
Glycine—GLYAT—Metabolism—HDC—Gilles de la Tourette syndrome	0.00231	0.00633	CbGpPWpGaD
Glycine—GATM—Metabolism—HDC—Gilles de la Tourette syndrome	0.00231	0.00633	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—HDC—Gilles de la Tourette syndrome	0.00231	0.00633	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—HDC—Gilles de la Tourette syndrome	0.00231	0.00633	CbGpPWpGaD
Glycine—BAAT—Metabolism—HDC—Gilles de la Tourette syndrome	0.0022	0.00604	CbGpPWpGaD
Glycine—GPR18—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00218	0.00597	CbGpPWpGaD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.002	0.00549	CbGpPWpGaD
Glycine—AGXT—Metabolism—HDC—Gilles de la Tourette syndrome	0.00196	0.00538	CbGpPWpGaD
Glycine—GRIN2C—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00193	0.00528	CbGpPWpGaD
Glycine—SLC6A9—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00192	0.00528	CbGpPWpGaD
Glycine—SLC6A5—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00192	0.00528	CbGpPWpGaD
Glycine—ALAS1—Metabolism—HDC—Gilles de la Tourette syndrome	0.0019	0.00521	CbGpPWpGaD
Glycine—SLC36A1—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00185	0.00507	CbGpPWpGaD
Glycine—AGXT2—Metabolism—HDC—Gilles de la Tourette syndrome	0.00167	0.00458	CbGpPWpGaD
Glycine—GLRA3—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00164	0.00449	CbGpPWpGaD
Glycine—SLC32A1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00164	0.00449	CbGpPWpGaD
Glycine—GLRA2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00164	0.00449	CbGpPWpGaD
Glycine—GPR18—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00153	0.00418	CbGpPWpGaD
Glycine—GRIN2C—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00148	0.00405	CbGpPWpGaD
Glycine—GRIN2A—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00147	0.00403	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00136	0.00373	CbGpPWpGaD
Glycine—SHMT1—Metabolism—HDC—Gilles de la Tourette syndrome	0.00136	0.00373	CbGpPWpGaD
Glycine—GLRB—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00133	0.00366	CbGpPWpGaD
Glycine—GSS—Metabolism—HDC—Gilles de la Tourette syndrome	0.00133	0.00364	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00132	0.00362	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00124	0.00339	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00123	0.00337	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.0012	0.00329	CbGpPWpGaD
Glycine—GRIN2A—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00113	0.00309	CbGpPWpGaD
Glycine—SLC16A10—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00112	0.00308	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00112	0.00306	CbGpPWpGaD
Glycine—GLRA1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00105	0.00289	CbGpPWpGaD
Glycine—SLC36A1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00094	0.00258	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000862	0.00236	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000783	0.00215	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00073	0.002	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000709	0.00194	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00066	0.00181	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000571	0.00157	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000462	0.00127	CbGpPWpGaD
